Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.5M | 22 | 100.0% |
| Food and Beverage | $3.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1.5M | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $642,010 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($642,010) |
| 2023 | $315,128 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($315,128) |
| 2022 | $245,108 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($245,108) |
| 2021 | $301,786 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($301,786) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $70,280.00 | General |
| 12/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $51,150.00 | General |
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $107,457.00 | General |
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $74,840.00 | General |
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $73,005.00 | General |
| 06/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $91,510.43 | General |
| 06/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $46,240.00 | General |
| 06/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $22,320.00 | General |
| 03/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $90,923.26 | General |
| 03/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $14,280.00 | General |
| 02/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $3.95 | General |
| 12/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $78,007.05 | General |
| 09/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $102,139.97 | General |
| 06/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $63,561.31 | General |
| 03/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $71,419.44 | General |
| 12/31/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $56,100.00 | General |
| 09/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $74,167.50 | General |
| 06/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $55,027.50 | General |
| 03/31/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $59,812.50 | General |
| 12/31/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $57,173.00 | General |
| 09/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $78,540.00 | General |
| 06/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $82,830.00 | General |
| 03/31/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $83,243.00 | General |
About Dr. Russell Carlisle, DO
Dr. Russell Carlisle, DO is a Family Medicine healthcare provider based in Wesson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2021. The National Provider Identifier (NPI) number assigned to this provider is 1689263717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Russell Carlisle, DO has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $642,010 received in 2024. These payments were reported across 23 transactions from 1 company. The most common payment nature is "Consulting Fee" ($1.5M).
Practice Information
- Specialty Family Medicine
- Location Wesson, MS
- Active Since 01/13/2021
- Last Updated 01/13/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689263717
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.